Group 6 Copy 83
1
Please wait...

About This Project

The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.

Blast off!

Browse Other Projects on Experiment

Related Projects

How does taking Ritalin affect depersonalization-derealization disorder patients?

We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...

Can hair loss be reversed with Oxy133, a sterol based drug candidate?

Hair loss can affect both men and women, often leaving a negative impact on the affected person’s life...

Can blood lactate levels help guide treatment for birds suffering from monofilament line entanglement injuries?

Fishing line entanglement injuries are a common problem affecting over 200 different wildlife species globally...

Backer Badge Funded